Clinical Trial Update: Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

This Clinical Trial Update describes a Phase 1 study of hypofractionated re-irradiation for good-prognosis recurrent glioblastoma, sponsored by the National Can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma
• Glioma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Astrocytoma, Glioma | Phase 1 | Status: RECRUITING